167 related articles for article (PubMed ID: 1722395)
1. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.
Oikawa T; Hasegawa M; Shimamura M; Ashino H; Murota S; Morita I
Biochem Biophys Res Commun; 1991 Dec; 181(3):1070-6. PubMed ID: 1722395
[TBL] [Abstract][Full Text] [Related]
2. Possible functional groups responsible for inhibition of in vivo angiogenesis by herbimycin A.
Oikawa T; Ogasawara H; Sano H; Shibata K; Omura S
Biol Pharm Bull; 1994 Oct; 17(10):1430-2. PubMed ID: 7533023
[TBL] [Abstract][Full Text] [Related]
3. Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.
Oikawa T; Sasaki M; Inose M; Shimamura M; Kuboki H; Hirano S; Kumagai H; Ishizuka M; Takeuchi T
Anticancer Res; 1997; 17(3C):1881-6. PubMed ID: 9216639
[TBL] [Abstract][Full Text] [Related]
4. Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells.
Oikawa T; Hasegawa M; Morita I; Murota S; Ashino H; Shimamura M; Kiue A; Hamanaka R; Kuwano M; Ishizuka M
Anticancer Drugs; 1992 Jun; 3(3):293-9. PubMed ID: 1381973
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
[TBL] [Abstract][Full Text] [Related]
6. Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis.
Oikawa T; Ito H; Ashino H; Toi M; Tominaga T; Morita I; Murota S
Eur J Pharmacol; 1993 Sep; 241(2-3):221-7. PubMed ID: 7694864
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
BenEzra D
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2433-4. PubMed ID: 9375559
[No Abstract] [Full Text] [Related]
8. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
[TBL] [Abstract][Full Text] [Related]
9. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic activity of triterpene acids.
Sohn KH; Lee HY; Chung HY; Young HS; Yi SY; Kim KW
Cancer Lett; 1995 Aug; 94(2):213-8. PubMed ID: 7543366
[TBL] [Abstract][Full Text] [Related]
11. Eponemycin analogues: syntheses and use as probes of angiogenesis.
Sin N; Meng L; Auth H; Crews CM
Bioorg Med Chem; 1998 Aug; 6(8):1209-17. PubMed ID: 9784862
[TBL] [Abstract][Full Text] [Related]
12. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by rhizoxin, a microbial metabolite containing two epoxide groups.
Onozawa C; Shimamura M; Iwasaki S; Oikawa T
Jpn J Cancer Res; 1997 Dec; 88(12):1125-9. PubMed ID: 9473728
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of angiogenesis by wortmannin, a fungal metabolite.
Oikawa T; Shimamura M
Eur J Pharmacol; 1996 Dec; 318(1):93-6. PubMed ID: 9007518
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
[TBL] [Abstract][Full Text] [Related]
17. DNA chip analysis of comprehensive food function: inhibition of angiogenesis and telomerase activity with unsaturated vitamin E, tocotrienol.
Nakagawa K; Eitsuka T; Inokuchi H; Miyazawa T
Biofactors; 2004; 21(1-4):5-10. PubMed ID: 15630161
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase.
Oikawa T; Ashino H; Shimamura M; Hasegawa M; Morita I; Murota S; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1993 May; 46(5):785-90. PubMed ID: 7685752
[TBL] [Abstract][Full Text] [Related]
19. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
[TBL] [Abstract][Full Text] [Related]
20. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.
Favot L; Keravis T; Holl V; Le Bec A; Lugnier C
Thromb Haemost; 2003 Aug; 90(2):334-43. PubMed ID: 12888882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
